Apaf-1 facilitates the proteolytic activation of procaspase-9 and maintains the hyperactive state of the processed caspase-9. The underlying molecular mechanisms for these activities remain poorly characterized. Here we report that the isolated Apaf-1 caspase recruitment domain (CARD) forms a large hetero-oligomer with the active caspase-9. The catalytic activity of caspase-9 is significantly enhanced in this complex, demonstrating that Apaf-1 CARD allosterically up-regulates caspase-9 activity. Point mutations that inactivate the interactions between Apaf-1 CARD and the prodomain of caspase-9 also abolished the formation of this complex. Based on these observations, we discuss the implications of this complex on the observed Apaf-1 function.
contains 10 mM HEPES (pH 7.5), 100 mM NaCl, and 2 mM DTT. To ensure complex formation, the individual components were incubated for 30 min before gel filtration.
Crystallization and Data Collection. Crystals of caspase-9 prodomain were grown by the hanging-drop vapor-diffusion method by using a reservoir solution containing 1.5 M (NH 4 ) 2 HPO 4 . The crystals are in the space group I23, with unit cell dimensions a ϭ b ϭ c ϭ 86.4 Å, and contain one molecule per asymmetric unit. Crystals were equilibrated in a cryoprotectant buffer containing well buffer plus 20% glycerol, and were frozen in a Ϫ170°C nitrogen stream. The native data set was processed by using DENZO and SCALEPACK (27) . The native data have a 4.5-fold overall redundancy, an R sym of 0.067, and 97.3% completeness to 2.1 Å resolution.
Structure Determination. The structure was determined by using the software AMORE (28) , using the atomic coordinates of Apaf-1 CARD (PDB ID code 3ygs). The model was examined by using O (29) , and the Apaf-1 CARD side chains were replaced with those of caspase-9 prodomain. Refinement by the program CNS (30) resulted in 20.6% and 25.5% for the final R-factor and R-free, respectively. The final atomic model contains caspase-9 residues 1-99 and 39 water molecules at 2.1 Å resolution. The rms deviation for bonds and angles are 0.005 Å and 1.145°, respectively.
Results

Formation of a Heterodimer Between Apaf-1 CARD and Caspase-9
Prodomain. In the crystal structure, the isolated Apaf-1 CARD forms a heterodimer with the isolated prodomain of caspase-9 (22) . To confirm this observation in solution, we devised an in vitro interaction assay, using size exclusion chromatography. The elution volume of Apaf-1 CARD corresponds to a monomer (11 kDa) (Fig. 1A) . The elution volume of caspase-9 prodomain corresponds to Ϸ23 kDa ( Fig. 1 A) , larger than that expected for a monomer (15 kDa). This difference is likely caused by the enlarged radius of hydration because of the C-terminal flexible sequence of the caspase-9 prodomain. When equimolar amounts of Apaf-1 CARD and caspase-9 prodomain were used, there was little protein at the elution volume for either of the individual components, indicating a 1:1 stoichiometry (Fig. 1 A) . In addition, the elution volume for the complex corresponds to an apparent molecular weight of 34 kDa, consistent with a 1:1 complex of Apaf-1 CARD and caspase-9 prodomain (Fig. 1 A) .
Apaf-1 CARD Oligomerizes Caspase-9. Apaf-1 CARD is responsible for the recruitment of procaspase-9 (12, 22) . After autoprocessing, the mature caspase-9 remains bound to the apoptosome, and the isolated caspase-9 is only marginally active (17) . This observation indicates that caspase-9 must undergo some conformational change on binding to the apoptosome. One possibility is that Apaf-1 binding could induce a conformational change in the catalytic subunit of caspase-9. In this case, because CARD is the only domain of Apaf-1 known to interact with caspase-9, complex formation between the CARD and the prodomain likely creates a novel interface that facilitates interactions with the catalytic subunit of caspase-9, allosterically activating it.
To examine this scenario, we incubated Apaf-1 CARD with the processed caspase-9 and applied the complex to size exclusion chromatography (Fig. 1B Bottom) . If the interactions were restricted to those between the CARD and the prodomain, the resulting complex would be a heterotetramer, comprising a caspase-9 homodimer and two bound CARD molecules. In this case, the complex is expected to display a combined molecular weight of Ϸ110 kDa, similar to that of the caspase-9 homodimer. Surprisingly, the elution volume of the primary complex corresponds to Ϸ300-400 kDa, far greater than that of the caspase-9 homodimer (Ϸ90 kDa, Fig. 1B Top) . Thus, Apaf-1 CARD induces the formation of a large multimeric complex involving caspase-9, hereafter referred to as the ''CARD/caspase-9 complex.''
The formation of this CARD/caspase-9 complex is concentration dependent because the caspase-9:CARD heterotetramer (Ϸ110 kDa) was also present in a separate peak despite excess amount of CARD (Fig. 1B Bottom) . Higher concentrations of caspase-9 and excess Apaf-1 CARD drives the equilibrium toward the formation of the CARD/caspase-9 complex, as judged by the diminished peak of the caspase-9:CARD heterotetramer (data not shown).
To examine whether the formation of this CARD/caspase-9 complex is dependent on the interactions between Apaf-1 CARD and caspase-9 prodomain, we incubated caspase-9 with a mutant CARD (D27A), which does not interact with the prodomain (22) . In this case, no complex formation was detected (data not shown), demonstrating that the interactions between Apaf-1 CARD and the prodomain of caspase-9 are a prerequisite for the formation of the CARD/caspase-9 complex.
Enhanced Caspase-9 Activity in the CARD/Caspase-9 Complex. To further characterize this complex, we reconstituted an in vitro caspase-9 assay by using its physiological substrate procaspase-3. To ensure that the cleavage of this substrate is a direct readout of caspase-9 activity, we introduced a point mutation in the substrate, changing its catalytic residue Cys-163 to an Ala (C163A).
The isolated caspase-9 exhibits a basal level of activity, as judged by the cleavage of procaspase-3 precursor into the p20 and p12 subunits ( Fig. 2A , lane 2). Interestingly, this activity is significantly enhanced in the presence of Apaf-1 CARD (lane 4) whereas CARD by itself does not have any enzymatic activity (lane 3). The addition of the inhibitory XIAP-BIR3 completely blocked the cleavage of procaspase-3 by caspase-9 (lanes 5 and 6). Because the formation of the CARD/caspase-9 complex is concentration dependent, the increased activity of caspase-9 is also expected to depend on the concentrations of the CARD. Indeed, increasing amounts of CARD progressively elevated the enzymatic activity of caspase-9 ( Fig. 2B ). To demonstrate that the elevated caspase-9 activity is due to the formation of the CARD/caspase-9 complex, we showed that a mutant CARD (D27A), which cannot form this complex, has no impact on the basal-level activity of caspase-9 ( Fig. 2C) .
Because the formation of the CARD/caspase-9 complex depends on the interactions between Apaf-1 CARD and caspase-9 prodomain, the prodomain by itself should antagonize the formation of this complex by competing with caspase-9 for binding to the CARD. Indeed, the wild-type (wt) prodomain is able to abolish the formation of this complex in a concentrationdependent manner (Fig. 2D , lanes 4-6). In contrast, a mutant prodomain (R56A), which does not interact with CARD (22) , exhibited no effect (Fig. 2D , lanes 7-9).
The Prodomain of Caspase-9 Is Important for Its Activity. One possible explanation for the CARD-mediated caspase-9 activation is that the prodomain of caspase-9 may inhibit its catalytic activity and binding by CARD could relieve this inhibition. To examine this possibility, we generated a caspase-9 (residues 148-416, termed ''caspase-9 (⌬N)'') with the prodomain removed. During over-expression in bacteria, this variant undergoes the same proteolytic activation as the wt caspase-9.
We first compared the basal-level activity of caspase-9 (⌬N) to that of the wt caspase-9 (Fig. 3A) . Surprisingly, removal of the prodomain renders the resulting caspase-9 (⌬N) much less active (Fig. 3A, lanes 1 and 5) , indicating that the prodomain is important for the maintenance of caspase-9 basal-level activity. In contrast to the wt caspase-9, caspase-9 (⌬N) does not interact with Apaf-1 CARD and can no longer form the CARD/ caspase-9 complex; thus its activity remains the same regardless of CARD (lanes 5 and 6). Because the catalytic site is intact in both cases, XIAP-BIR3 still potently inhibits both the wt and the prodomain-deleted caspase-9 (lanes 3, 4, 7, and 8).
To quantitatively compare caspase-9 activity in the absence and presence of Apaf-1 CARD, we measured the percentage of cleaved substrates (Fig. 3 B and C) . This analysis reveals that caspase-9 exhibits Ϸ5-fold higher activity in the presence of 20 M CARD than in its absence, whereas caspase-9 (⌬N) exhibits Ϸ20% activity of the wt caspase-9. As formation of the CARD/ caspase-9 complex is concentration dependent, higher concentrations of CARD further improved the catalytic activity of caspase-9 (data not shown).
Effect of Full-Length Apaf-1. Our observations demonstrate that Apaf-1 CARD is sufficient for the maintenance of the hyperactive state of caspase-9 in a concentration-dependent manner. To compare the effect of Apaf-1 CARD to that of the full-length Apaf-1, we reconstituted another caspase-9 assay by using purified full-length Apaf-1, cytochrome c, dATP, and the physiological substrate procaspase-3 (C163A) (Fig. 4A ). Caspase-9 by itself exhibits a basal-level activity (Fig. 4A, lane 1) . This activity was not improved upon incubation with 10 M cytochrome c (lane 2), 1 mM dATP (lane 3), 0.2 M full-length Apaf-1 (lane 4), or any two of the three components (lanes 5, 6, and 7). In contrast, incubation with Apaf-1 in the presence of dATP and cytochrome c significantly enhanced caspase-9 activity (lanes 8 and 9). This result confirms that the holoenzyme comprises three proteins (Apaf-1, caspase-9, and cytochrome c) and one critical cofactor (dATP) and that the absence of any component abrogates the formation of the holoenzyme.
Next, we compared caspase-9 activity in the presence of the full-length Apaf-1 or the CARD (Fig. 4 B and C) . Both promoted caspase-9 activity; but the full-length Apaf-1 appears to be much more efficient. Although this observation appears to argue that caspase-9 in the holoenzyme has much higher activity than that in the CARD/caspase-9 complex, it in fact does not and the discrepancy can be explained by the observed differences in association affinity.
The association affinity for the CARD/caspase-9 complex is relatively low. At Ϸ100 M concentrations of the CARD and caspase-9, the formation of the CARD/caspase-9 complex was still incomplete (Fig. 1B) . In the in vitro assays, the caspase-9 and CARD concentrations were 0.2 and 20 M, respectively (Fig. 4  B and C) . At these concentrations, the vast majority of caspase-9 (Ͼ98%) is estimated to remain unbound to this complex and thus exhibits only the basal-level activity. In the case of the full-length Apaf-1, the association affinity for the holoenzyme is very high. At Ϸ1 M concentration each, free caspase-9 was undetectable. Presumably, this increased association affinity is due to the homo-oligomeric interactions of the CED-4 homology domain in Apaf-1.
A Model of the CARD/Caspase-9 Complex. We demonstrated that the interactions between Apaf-1 CARD and the prodomain of caspase-9 are indispensable to the formation of the CARD/ caspase-9 complex. Because the isolated CARD only forms a heterodimer with the isolated prodomain, an additional interface between the CARD and caspase-9 has to be involved to facilitate the formation of this multimeric complex.
Where is this novel interface located on caspase-9? To help answer this question, we determined the crystal structure of caspase-9 prodomain by itself (Fig. 5A ). Comparison analysis reveals that the structures of caspase-9 prodomain by itself and in complex with the CARD are nearly identical to each other, with 0.36 Å rms deviation for all 97 aligned C␣ atoms (Fig. 5A) . Similar to the CARD, the surface of the prodomain is enriched with charged residues, which form two acidic and one basic patches (Fig. 5B) . In the heterodimer, one acidic surface of Apaf-1 CARD is recognized by a basic surface on the prodomain of caspase-9 (22) . This arrangement leaves the other charged surfaces intact on the complex. During characterization of the CARD/caspase-9 complex, we found that oligomerization of caspase-9 by the CARD is abolished at elevated ionic strength, such as 500 mM NaCl. Under this condition, caspase-9 exhibits only a basal level of activity despite the fact that caspase-9 retained formation of a 2:2 heterotetramer with the CARD. These observations suggest that the interactions responsible for caspase-9 oligomerization are predominantly electrostatic in nature. Thus it is likely that the other charged surfaces on the CARD:prodomain heterodimer are involved in oligomerizing caspase-9 through electrostatic interactions (Fig. 6 ). These interactions may in turn rearrange the active site of caspase-9 to better accommodate substrates, thus enhancing activity.
To support this model, we looked for missense mutations in the catalytic subunits of caspase-9 that would disrupt the CARD/ caspase-9 complex but not a heterotetramer between caspase-9 and the CARD. Interestingly, we found that C287A mutation in the active site of caspase-9 completely disrupted this complex while retaining the formation of a heterotetramer with the CARD. In contrast, a number of other mutations in the vicinity of the active site (such as D315A or D293A/D315A) exhibited no impact on the formation of this complex. These observations demonstrate that the CARD/caspase-9 complex is formed through highly specific interactions. In the crystal structure of caspase-9 (31), Cys-287 interacts with surrounding residues through van der Waals contacts, which are likely important for the CARD-mediated oligomerization. The C287A mutation presumably disrupts these local interactions and prevents the CARD-mediated oligomerization of caspase-9.
Discussion
The processed caspase-9 and Apaf-1 CARD together form a Ϸ300-400-kDa concentration-dependent complex. Several lines of evidence indicate that this complex is highly specific and may recapitulate some aspects of the holoenzyme. First, the formation of this CARD/caspase-9 complex depends on the interaction between Apaf-1 CARD and caspase-9 prodomain. Mutations that inactivate a CARD-prodomain hetero-dimer also abrogated the formation of this complex. Second, caspase-9 exists in a hyperactive state in this complex. Although caspase-9 was only 5-fold more active in the presence of 20 M CARD, higher levels of activity were recorded with higher concentrations of Apaf-1 CARD. When taking into account the differences in association affinities, the activity of caspase-9 in this complex is comparable to that in the holoenzyme. Third, we identified at least one missense mutation in the catalytic site of caspase-9 (C287A) that abolished formation of this complex but not the heterotetramer with Apaf-1 CARD.
If this CARD/caspase-9 complex indeed recapitulates the holoenzyme (with the omission of the bulk of Apaf-1 and cytochrome c), it can explain the observed biochemical properties of Apaf-1. For example, the CED-4 homology domain of Apaf-1 is known to form a homo-oligomer (23, 24) . This activity is expected to greatly strengthen the CARD/caspase-9 complex 6 . A model of the CARD/caspase-9 complex. In this model, the building block is the CARD:prodomain heterodimer, which creates a novel surface onto which the catalytic subunit of caspase-9 docks. This docking stabilizes the interactions between two units of the CARD:prodomain heterodimer, which forms a donut-shaped structure. This docking also rearranges the active site of caspase-9 for higher activity. The CARD/caspase-9 complex may resemble the holoenzyme, in which oligomerization is further stabilized by the CED-4 homology domain of Apaf-1.
by providing additional energy, explaining the higher association affinity for the holoenzyme. In the CARD/caspase-9 complex, the catalytic subunit of caspase-9 is likely to be in direct contact with the CARD/prodomain complex through electrostatic interactions, which rearrange the catalytic site of caspase-9 for higher activity.
Our observations also have significant implications for the activation process of procaspase-9. Because the bound procaspase-9 in the holoenzyme presumably rearranges its active site before autoprocessing, it is possible that the elevated enzymatic activity of the rearranged procaspase-9 is the true cause of proteolytic autoactivation, rather than that predicted by ''induced proximity.'' If Apaf-1 CARD forms a large complex with caspase-9, then why is the full-length Apaf-1 by itself insufficient for this activity? (Fig. 4A, lane 4) . The reason is that the full-length Apaf-1 by itself does not interact with the processed caspase-9. The association with cytochrome c and dATP changes the conformation of Apaf-1, enabling it to recruit caspase-9 (12, 19, 25, 32) .
Using dATP-activated cell lysates, two different sizes (700 and 1,400 kDa) of the Apaf-1-containing apoptosome were recently identified and only the 700-kDa complex was shown to be active (33) . These results are in contrast to other studies that revealed only one size for the apoptosome (Ϸ1,400 kDa) by using purified recombinant proteins (15) (16) (17) . It is unclear at present how to reconcile this discrepancy. In addition, the CARD/caspase-9 complex described here is not related to the reported ''microaposome'' that mainly contains active caspase-3 and -7 but little Apaf-1 or caspase-9 (34). More recently, Apaf-1 was reported to undergo proteolytic cleavage during apoptosis (35, 36) . In one case, caspase-3 was found to cleave Apaf-1 in the CED-4 homology domain to generate a 30-kDa N-terminal fragment. Although this fragment is unable to promote caspase-9 maturation (35) , it may be able to maintain the processed caspase-9 in a hyperactive state to promote apoptosis, much the same way as Apaf-1 CARD.
While this paper was in review, caspase-9 structure was reported (31) . In this study, caspase-9 was found to exist in an equilibrium between monomers and dimers and only the dimeric form was active (31) . Thus the activation of caspase-9 was attributed to dimer formation (31) . Under our experimental conditions, we have only observed one form of caspase-9, which is active. This dimeric form of caspase-9 can be further activated by Apaf-1 or the CARD (Figs. 3 and 4) . We do not yet know the precise stoichiometry for the constituents of the CARD/ caspase-9 complex. The relatively low association affinity for this complex makes determination of its precise molecular weight difficult.
In summary, we demonstrate the formation of a multimeric complex between Apaf-1 CARD and caspase-9 in which the enzymatic activity of caspase-9 is significantly elevated. Although formation of the CARD/caspase-9 complex may lack physiological significance, our observations reveal important insights into the mechanism of caspase-9 activation by Apaf-1, a biologically significant process. The biochemical nature of this complex remains speculative. Nevertheless, these findings suggest a link between the observed CARD/caspase-9 complex and the holoenzyme.
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